INDIAN BENCHMARK rebound from their recent losses and open higher tracking firm global cues even as upside gains may be capped ahead of the outcome of the US Fed policy meet which ends later today.
FURTHER, Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration to manufacture and market Amoxicillin for Oral Suspension USP. GAIL board will mull borrowing limit up to Rs 2,000 crore today. The company is mulling entering deal with RGPPL for use of its Dabhol LNG terminal for 25 years.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Tuesday while the DIIs were net buyers of Rs. 465cr, as per the provisional figures released by the NSE.
Get free trading in equity tips, free equity tips, stock tips, stock cash tips, stock futures tips, commodity tips, nifty tips, nifty futures, mcx tips, ncdex tips, and share market tips etc.
FURTHER, Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration to manufacture and market Amoxicillin for Oral Suspension USP. GAIL board will mull borrowing limit up to Rs 2,000 crore today. The company is mulling entering deal with RGPPL for use of its Dabhol LNG terminal for 25 years.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Tuesday while the DIIs were net buyers of Rs. 465cr, as per the provisional figures released by the NSE.
Get free trading in equity tips, free equity tips, stock tips, stock cash tips, stock futures tips, commodity tips, nifty tips, nifty futures, mcx tips, ncdex tips, and share market tips etc.
About Pooja Pariya
0 comments:
Post a Comment